DR. BRYAN LEROY WALSER, M.D.
Osteopathic Medicine at University Dr, Menlo Park, CA

License number

California G83742

Personal information

See more information about BRYAN LEROY WALSER at radaris.com

Name

Address

Phone

Bryan Walser, age 60

309 University Dr, Menlo Park, CA 94025

Bryan Walser

4560 Horton St, Emeryville, CA 94608

Professional information

Ceo &Amp; Co-Founder At Allergen Research Corporation

Position:

CEO & Co-founder at Allergen Research Corporation

Location:

San Francisco Bay Area

Industry:

Biotechnology

Work:

Allergen Research Corporation - Menlo Park, CA since Nov 2011 - CEO & Co-founder Perlegen Sciences, Inc. Apr 2007 - Jun 2012 - CEO Akrotome Imaging - Menlo Park, CA Jun 2010 - May 2012 - CEO Chiron Corporation Nov 2001 - Apr 2006 - VP, Strategy & Corporate Affairs The Boston Consulting Group Apr 1997 - Oct 2001 - Project Leader; Special Adviser

Education:

Harvard Law School 1992 - 1996
JD, Law University of Virginia School of Medicine 1987 - 1991
MD, Medicine Stanford University 1984 - 1986
BS, Biology

Languages:

Spanish, Portuguese, Indonesian

Dr. Bryan L Walser, Menlo Park CA - MD (Doctor of Medicine)

Specialties:

Internal Medicine

Address:

309 University Dr, Menlo Park 94025
(510) 501-7046 (Phone)

Languages:

English

Education:

Medical School
University of Virginia / Main Campus
Graduated: 1991

Methods For Breast Cancer Risk Assessment

US Patent:

2011029, Dec 1, 2011

Filed:

Jun 1, 2010

Appl. No.:

12/920815

Inventors:

David A. Hinds - Sunnyvale CA, US
Bryan Walser - Menlo Park CA, US

International Classification:

C12Q 1/68, C40B 30/04, G06F 19/10

US Classification:

506 9, 702 19, 435 611

Abstract:

The present invention relates to methods and systems for assessing the overall risk of a human female subject for developing a breast cancer phenotype. In particular, the present invention relates to combining clinical risk assessment and genetic risk assessment to improve risk analysis.